| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |